TD Asset Management »

Summit Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 538k 20.66
2025-06-30 $10M 484k 21.28
2025-03-31 $16M 807k 19.29
2024-12-31 $15M 838k 17.85
2024-09-30 $15M 695k 20.89
2024-06-30 $2.1M 267k 7.80